What does Polaryx Therapeutics, Inc. do?

Polaryx Therapeutics, Inc. is a public company in the Pharmaceutical Preparations industry, incorporated in WY. It is registered with the SEC under CIK 0002075320 and trades on NASDAQ under the ticker PLYX.

Is Polaryx Therapeutics, Inc. profitable?

Polaryx Therapeutics, Inc. reported a net loss of $8.99M in FY2025. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Polaryx Therapeutics, Inc. made?

Polaryx Therapeutics, Inc. has filed 23 documents with the SEC since 2025. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Polaryx Therapeutics, Inc.

PLYX NASDAQ CIK: 0002075320 Pharmaceutical Preparations Inc. in WY

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 23 filings →

Form	Description	Date
10-K	ANNUAL REPORT	Mar 24, 2026
4	—	Feb 20, 2026
SCHEDULE 13D	—	Feb 5, 2026
424B4	PROSPECTUS	Feb 2, 2026
EFFECT	—	Jan 29, 2026
3	OWNERSHIP DOCUMENT	Jan 29, 2026
3	OWNERSHIP DOCUMENT	Jan 29, 2026
3	OWNERSHIP DOCUMENT	Jan 29, 2026
3	OWNERSHIP DOCUMENT	Jan 29, 2026
3	OWNERSHIP DOCUMENT	Jan 29, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Polaryx Therapeutics, Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: ($8.99M) (FY2025)
Total Assets: $5.17M (FY2025)
Operating Income: ($7.82M)

Full financials →

Details

CIK: 0002075320
Ticker: PLYX
Exchange: NASDAQ
Incorporated: WY
First Filing: 2025
Total Filings: 23

Pharmaceutical Preparations rankings →